Tournament season may dominate the headlines, but in the benefits world, employers are playing their own high-stakes game
Discussion The clinical management of patients with type 2 diabetes has to balance the potential benefits of controlling hyperglycemia on microvascular and macrovascular complications, [11] with possible side effects of treatment and possible harm from over intensive control of glycemia
Final thoughts BPC-157 is an interesting compound that is also widely misunderstood
A major inflammatory mediator, tumor necrosis factor-alpha (TNF-), has been implicated as a driving force behind this inflammation (Guerra-Infante 1999
How it works : Every plan begins with an in-office consultation, tailored dosing, and ongoing support for a sustainable, science-backed way to feel your best
Safety monitoring for cardiovascular parameters is conducted within the clinical trial setting